Steel & Iron Products · Founded 1973 · www.midhani-india-in · BSE 541195 · NSE MIDHANI · ISIN INE099Z01011
No Notes Added Yet
Business
Mishra Dhatu Nigam Ltd. (MIDHANI) is an Indian state-owned enterprise engaged in the manufacturing and supply of high-performance special metals and alloys. Its core business involves producing superalloys, titanium alloys, special purpose steels, and other advanced metallurgical products. These materials are critical for applications requiring high strength-to-weight ratio, high temperature resistance, corrosion resistance, and specific magnetic/mechanical properties. MIDHANI primarily serves strategic sectors like defense, aerospace, nuclear power, and space, making money by supplying these specialized materials for various defense platforms, aircraft components, missile systems, nuclear reactors, and space launch vehicles.
Revenue Mix
MIDHANI's revenue is primarily derived from the sale of various high-performance alloys and special steels. While specific granular breakdowns can fluctuate, its key customer segments broadly align with the strategic sectors it serves:
Defence: Supply of materials for missile programs, naval applications, ordnance factories, and other defense systems.
Aerospace: Providing alloys for aircraft engines, airframes, and space launch vehicles.
Nuclear & Power: Materials for nuclear reactors, thermal power plants, and other energy infrastructure.
Others: Includes materials for general engineering, medical implants, and industrial applications.
Due to the strategic nature of its products, the largest share of its revenue typically comes from the defense and aerospace sectors.
Industry
MIDHANI operates in a highly specialized niche within the steel and iron products sector, focusing on high-performance alloys. The industry is characterized by high barriers to entry due to stringent quality standards, extensive R&D requirements, specialized manufacturing processes, and long product qualification cycles. Globally, it competes with a few large specialized alloy manufacturers. In India, MIDHANI holds a unique and largely monopolistic position as the primary indigenous supplier of many critical superalloys, titanium alloys, and special steels essential for defense, aerospace, and nuclear applications, often serving as a strategic partner to organizations like DRDO, ISRO, and HAL.
MOAT
MIDHANI possesses several durable competitive advantages:
Proprietary Technology & Expertise: Accumulation of decades of specialized metallurgical knowledge, processing capabilities, and intellectual property.
Strategic Importance: Its role as a crucial supplier for India's strategic sectors (defense, aerospace, nuclear) gives it preferred status and significant government backing.
High Switching Costs: The qualification process for high-performance materials in critical applications is extremely long and expensive, creating significant switching barriers for customers once a material is qualified.
Government Support: Being a Public Sector Undertaking (PSU) under the Ministry of Defence provides it with stable funding for R&D and capital expenditure, and ensures a sustained demand pipeline.
Growth Drivers
"Make in India" & "Aatmanirbhar Bharat" Initiatives: Government push for self-reliance in defense and aerospace manufacturing is a significant driver, increasing domestic procurement and reducing import dependency for critical materials.
Increased Defence Spending: India's sustained focus on modernizing its armed forces and indigenizing defense production will drive demand for MIDHANI's products.
Growth in Aerospace & Space Sectors: Expanding domestic aerospace manufacturing, missile programs, and space exploration initiatives (e.g., Gaganyaan mission) will require more advanced materials.
Nuclear Power Expansion: India's plans to expand its nuclear power capacity will create demand for specialized materials for reactor components.
Diversification into Commercial Applications: Potential to leverage its expertise to cater to high-value commercial sectors like medical implants, oil & gas, and industrial tooling.
Risks
Dependency on Government Orders: A significant portion of revenue is tied to government and strategic sector orders, making it vulnerable to shifts in defense budgets, government policies, or project delays.
Raw Material Price Volatility: Reliance on imported exotic raw materials (e.g., nickel, titanium, cobalt) exposes it to global commodity price fluctuations and supply chain disruptions.
Technological Obsolescence: Continuous R&D and capital investment are required to keep pace with evolving material science and manufacturing technologies globally.
Long Product Development Cycles: The extended time required for new product development, testing, and qualification can delay revenue generation from new initiatives.
Competition from Imports: Despite its strategic position, for non-critical or less specialized applications, it may face competition from international players.
Management & Ownership
MIDHANI is a Public Sector Undertaking (PSU) under the administrative control of the Ministry of Defence, Government of India. The Government of India, through the Ministry of Defence, is the promoter and holds a majority stake in the company. The management comprises a board of directors appointed by the government, often drawn from relevant technical and administrative backgrounds, ensuring alignment with national strategic objectives and long-term vision rather than purely short-term commercial gains.
Outlook
MIDHANI holds a pivotal role in India's strategic autonomy, especially in defense and aerospace. The company is well-positioned to benefit from the government's strong emphasis on indigenous manufacturing, increased defense outlays, and expansion in critical sectors like space and nuclear energy. Its unique capabilities and high barriers to entry provide a strong foundational demand. However, its growth trajectory remains largely tied to government expenditure and project cycles, making it susceptible to policy shifts or budget constraints. Successful diversification into high-value commercial segments and sustained R&D efforts to stay at the forefront of material science will be key to long-term robust growth beyond its core strategic mandate.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 252 | 405 | 163 | 262 | 238 | 411 | 170 | 210 | 276 | 553 |
| Other Income | 6 | 8 | 8 | 9 | 7 | 8 | 7 | 9 | 8 | 14 |
| Total Income | 258 | 414 | 171 | 271 | 245 | 418 | 178 | 219 | 283 | 567 |
| Total Expenditure | 216 | 325 | 140 | 213 | 186 | 317 | 136 | 177 | 221 | 437 |
| Operating Profit | 42 | 89 | 31 | 57 | 59 | 101 | 41 | 42 | 62 | 130 |
| Interest | 9 | 8 | 7 | 8 | 7 | 7 | 6 | 6 | 6 | 7 |
| Depreciation | 14 | 15 | 15 | 16 | 16 | 16 | 16 | 17 | 17 | 17 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 19 | 65 | 9 | 34 | 36 | 77 | 19 | 19 | 39 | 107 |
| Provision for Tax | 6 | 18 | 4 | 10 | 11 | 21 | 6 | 6 | 12 | 29 |
| Profit After Tax | 12 | 46 | 5 | 24 | 25 | 56 | 13 | 13 | 27 | 78 |
| Adjustments | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 13 | 46 | 5 | 24 | 26 | 56 | 13 | 13 | 28 | 78 |
| Adjusted Earnings Per Share | 0.7 | 2.5 | 0.3 | 1.3 | 1.4 | 3 | 0.7 | 0.7 | 1.5 | 4.2 |
| #(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Net Sales | 711 | 713 | 813 | 859 | 872 | 1073 | 1074 | 1209 |
| Other Income | 37 | 36 | 20 | 31 | 38 | 30 | 31 | 38 |
| Total Income | 748 | 749 | 833 | 891 | 910 | 1103 | 1105 | 1247 |
| Total Expenditure | 526 | 514 | 567 | 596 | 613 | 878 | 855 | 971 |
| Operating Profit | 221 | 235 | 266 | 295 | 296 | 225 | 250 | 275 |
| Interest | 7 | 7 | 13 | 23 | 27 | 35 | 30 | 25 |
| Depreciation | 23 | 26 | 27 | 33 | 53 | 59 | 63 | 67 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 191 | 200 | 226 | 239 | 217 | 131 | 157 | 184 |
| Provision for Tax | 60 | 42 | 60 | 63 | 61 | 40 | 46 | 53 |
| Profit After Tax | 131 | 158 | 166 | 177 | 156 | 92 | 111 | 131 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 131 | 158 | 166 | 177 | 156 | 92 | 111 | 132 |
| Adjusted Earnings Per Share | 7 | 8.4 | 8.9 | 9.4 | 8.3 | 4.9 | 5.9 | 7.1 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 0% | 8% | 9% | 0% |
| Operating Profit CAGR | 11% | -5% | 1% | 0% |
| PAT CAGR | 21% | -14% | -7% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 1% | 21% | 15% | NA% |
| ROE Average | 8% | 9% | 12% | 13% |
| ROCE Average | 11% | 12% | 15% | 17% |
| #(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 835 | 957 | 1071 | 1190 | 1285 | 1319 | 1415 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 1 | 0 | 0 | 28 | 67 | 59 | 39 |
| Other Non-Current Liabilities | 456 | 743 | 745 | 760 | 709 | 752 | 775 |
| Total Current Liabilities | 534 | 697 | 643 | 802 | 801 | 775 | 686 |
| Total Liabilities | 1825 | 2396 | 2459 | 2779 | 2863 | 2905 | 2915 |
| Fixed Assets | 425 | 441 | 429 | 938 | 1016 | 1032 | 1074 |
| Other Non-Current Assets | 234 | 441 | 579 | 163 | 104 | 107 | 54 |
| Total Current Assets | 1166 | 1514 | 1451 | 1678 | 1744 | 1767 | 1787 |
| Total Assets | 1825 | 2396 | 2459 | 2779 | 2863 | 2905 | 2915 |
| #(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 1 | 14 | 10 | 34 | 10 | 14 | 16 |
| Cash Flow from Operating Activities | 296 | 204 | 176 | 5 | -35 | 216 | 217 |
| Cash Flow from Investing Activities | -205 | -195 | -115 | -68 | -3 | -65 | -96 |
| Cash Flow from Financing Activities | -78 | -13 | -37 | 39 | 43 | -148 | -126 |
| Net Cash Inflow / Outflow | 13 | -4 | 24 | -24 | 4 | 2 | -6 |
| Closing Cash & Cash Equivalent | 14 | 10 | 34 | 10 | 14 | 16 | 11 |
| # | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 6.97 | 8.44 | 8.88 | 9.43 | 8.34 | 4.9 | 5.92 |
| CEPS(Rs) | 8.21 | 9.83 | 10.32 | 11.19 | 11.17 | 8.02 | 9.3 |
| DPS(Rs) | 2.19 | 2.56 | 2.78 | 3.1 | 3.35 | 1.41 | 0.75 |
| Book NAV/Share(Rs) | 44.56 | 51.07 | 57.18 | 63.5 | 68.61 | 70.42 | 75.53 |
| Core EBITDA Margin(%) | 25.96 | 27.92 | 30.24 | 30.6 | 29.67 | 18.18 | 20.39 |
| EBIT Margin(%) | 27.89 | 29.14 | 29.38 | 30.44 | 27.97 | 15.56 | 17.43 |
| Pre Tax Margin(%) | 26.88 | 28.12 | 27.82 | 27.82 | 24.88 | 12.26 | 14.6 |
| PAT Margin (%) | 18.37 | 22.18 | 20.46 | 20.52 | 17.92 | 8.56 | 10.32 |
| Cash Profit Margin (%) | 21.63 | 25.84 | 23.78 | 24.36 | 24 | 14.01 | 16.23 |
| ROA(%) | 7.16 | 7.49 | 6.85 | 6.74 | 5.54 | 3.18 | 3.81 |
| ROE(%) | 15.64 | 17.65 | 16.41 | 15.63 | 12.63 | 7.05 | 8.11 |
| ROCE(%) | 21.06 | 20.45 | 20.58 | 19.49 | 15.58 | 10.07 | 11.37 |
| Receivable days | 180.87 | 166.31 | 153.39 | 146.84 | 130.21 | 108.68 | 124.6 |
| Inventory Days | 261.27 | 363.36 | 384.05 | 401.3 | 484.82 | 431.22 | 440.18 |
| Payable days | 248.27 | 393.37 | 184.92 | 250.07 | 360.47 | 108.14 | 90.36 |
| PER(x) | 20.24 | 21.19 | 19.89 | 17.54 | 22.11 | 80.38 | 46.06 |
| Price/Book(x) | 3.17 | 3.5 | 3.09 | 2.6 | 2.69 | 5.59 | 3.61 |
| Dividend Yield(%) | 1.55 | 1.43 | 1.57 | 1.87 | 1.82 | 0.36 | 0.28 |
| EV/Net Sales(x) | 3.59 | 4.73 | 4.15 | 3.84 | 4.39 | 7.16 | 4.92 |
| EV/Core EBITDA(x) | 11.52 | 14.32 | 12.71 | 11.21 | 12.91 | 34.16 | 21.16 |
| Net Sales Growth(%) | 0 | 0.29 | 14.08 | 5.69 | 1.45 | 23.02 | 0.13 |
| EBIT Growth(%) | 0 | 4.79 | 15.01 | 9.66 | -6.93 | -31.54 | 12.16 |
| PAT Growth(%) | 0 | 21.1 | 5.26 | 6.13 | -11.52 | -41.27 | 20.76 |
| EPS Growth(%) | 0 | 21.1 | 5.26 | 6.12 | -11.52 | -41.27 | 20.76 |
| Debt/Equity(x) | 0.13 | 0.14 | 0.15 | 0.22 | 0.3 | 0.25 | 0.17 |
| Current Ratio(x) | 2.19 | 2.17 | 2.26 | 2.09 | 2.18 | 2.28 | 2.61 |
| Quick Ratio(x) | 1.23 | 0.87 | 1.01 | 0.73 | 0.65 | 0.59 | 0.74 |
| Interest Cover(x) | 27.55 | 28.52 | 18.83 | 11.61 | 9.06 | 4.71 | 6.15 |
| Total Debt/Mcap(x) | 0.04 | 0.04 | 0.05 | 0.09 | 0.11 | 0.04 | 0.05 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74 | 74 | 74 | 74 | 74 | 74 | 74 | 74 | 74 | 74 |
| FII | 0.95 | 1.08 | 1.27 | 1.42 | 1.26 | 1.65 | 1.34 | 1.37 | 1.25 | 1.32 |
| DII | 11.84 | 11.03 | 9.33 | 8.45 | 8.49 | 8.79 | 8.98 | 8.83 | 7.92 | 7.82 |
| Public | 13.21 | 13.89 | 15.4 | 16.13 | 16.25 | 15.56 | 15.68 | 15.8 | 16.82 | 16.86 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 13.86 | 13.86 | 13.86 | 13.86 | 13.86 | 13.86 | 13.86 | 13.86 | 13.86 | 13.86 |
| FII | 0.18 | 0.2 | 0.24 | 0.27 | 0.24 | 0.31 | 0.25 | 0.26 | 0.23 | 0.25 |
| DII | 2.22 | 2.07 | 1.75 | 1.58 | 1.59 | 1.65 | 1.68 | 1.65 | 1.48 | 1.46 |
| Public | 2.47 | 2.6 | 2.89 | 3.02 | 3.05 | 2.92 | 2.94 | 2.96 | 3.15 | 3.16 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18.73 | 18.73 | 18.73 | 18.73 | 18.73 | 18.73 | 18.73 | 18.73 | 18.73 | 18.73 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 0% | +8% | +9% | — |
| Operating Profit CAGR | +11% | -5% | +1% | — |
| PAT CAGR | +21% | -14% | -7% | — |
| Share Price CAGR | +1% | +21% | +15% | — |
| ROE Average | +8% | +9% | +12% | +13% |
| ROCE Average | +11% | +12% | +15% | +17% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74 | 74 | 74 | 74 | 74 | 74 | 74 | 74 | 74 | 74 |
| FII | 0.95 | 1.08 | 1.27 | 1.42 | 1.26 | 1.65 | 1.34 | 1.37 | 1.25 | 1.32 |
| DII | 11.84 | 11.03 | 9.33 | 8.45 | 8.49 | 8.79 | 8.98 | 8.83 | 7.92 | 7.82 |
| Public | 26 | 26 | 26 | 26 | 26 | 26 | 26 | 26 | 26 | 26 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 13.86 | 13.86 | 13.86 | 13.86 | 13.86 | 13.86 | 13.86 | 13.86 | 13.86 | 13.86 |
| FII | 0.18 | 0.2 | 0.24 | 0.27 | 0.24 | 0.31 | 0.25 | 0.26 | 0.23 | 0.25 |
| DII | 2.22 | 2.07 | 1.75 | 1.58 | 1.59 | 1.65 | 1.68 | 1.65 | 1.48 | 1.46 |
| Public | 4.87 | 4.87 | 4.87 | 4.87 | 4.87 | 4.87 | 4.87 | 4.87 | 4.87 | 4.87 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18.73 | 18.73 | 18.73 | 18.73 | 18.73 | 18.73 | 18.73 | 18.73 | 18.73 | 18.73 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.